Ticker,Title,Link
PTGX,Buy Rating Affirmed for Protagonist Therapeutics Based on Strong Pipeline and Financial Health,8/7/2024 10:35:59 AM
PTGX,Protagonist Therapeutics Receives ‘Buy’ Rating on Strong Performance and Promising Pipeline,8/6/2024 11:45:42 PM
PTGX,Buy Rating for Protagonist Therapeutics: Expanding Pipeline and Strong Partnership Prospects,7/24/2024 11:06:44 AM
PTGX,3 Growth Stocks No One Is Watching (But They Should Be),7/11/2024 10:00:00 AM
PTGX,Protagonist Therapeutics set to join S&P SmallCap 600,6/28/2024 7:26:41 AM
PTGX,"Analysts Are Bullish on These Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Protagonist Therapeutics (PTGX)",6/16/2024 12:30:31 PM
PTGX,Positive Phase 3 Prospects for Protagonist Therapeutics’ Rusfertide: A Buy Rating Justified by REVIVE Trial Data,6/14/2024 6:55:25 PM
PTGX,"These Biotech Stocks Hit New Highs, Did You Reap The Rewards? ",6/7/2024 2:09:06 PM
PTGX,The 3 Best Biotech Stocks to Buy in June 2024,6/5/2024 5:35:02 PM
PTGX,Buy Rating Affirmed for Protagonist Therapeutics on Strong Financials and Promising Clinical Trials,5/9/2024 10:44:48 AM
PTGX,"Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), Nevro Corp (NVRO) and Precigen (PGEN)",5/8/2024 5:10:40 AM
PTGX,"Protagonist GAAP EPS of $3.26, revenue of $254.95M",5/7/2024 9:47:34 PM
PTGX,Protagonist Therapeutics Earns ‘Buy’ Rating on Strong Clinical Progress and Strategic Partnerships,3/27/2024 10:05:59 AM
PTGX,"Catalyst Watch: Walgreens earnings, UPS analyst day and Xiaomi's luxury EV debut",3/22/2024 7:00:00 PM
PTGX,"AUR, CDLX and PTGX are among after hour movers",3/14/2024 9:02:13 PM
PTGX,Buy Rating Affirmed for Protagonist Therapeutics on Strong Phase 2b Results and Strategic Phase 3 Dosing of JNJ-2113,3/11/2024 4:05:30 PM
PTGX,Johnson & Johnson highlights psoriasis candidate with long-term data,3/9/2024 6:34:43 PM
PTGX,"Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Progyny (PGNY) and Protagonist Therapeutics (PTGX)",2/28/2024 1:40:33 PM
PTGX,Protagonist Therapeutics Earns ‘Buy’ Rating: Promising Clinical Advances and Strategic Partnerships,2/9/2024 3:16:14 PM
PTGX,"3 Best Stocks to Buy Now, 2/2/2024, According to Top Analysts ",2/2/2024 4:49:36 AM
PTGX,Wall Street Analysts Are Bullish on Top Healthcare Picks,2/1/2024 5:00:59 PM
PTGX,"AGN, CHRW and KLIC are among after hour movers",1/31/2024 10:03:58 PM
PTGX,"3 Best Stocks to Buy Now, 1/29/2024, According to Top Analysts ",1/29/2024 8:20:55 AM
PTGX,Buy Rating on Protagonist Therapeutics: Anticipating Rusfertide Success and Strategic Acquisition Upside,1/26/2024 5:25:52 AM
PTGX,BTIG Reaffirms Their Buy Rating on Protagonist Therapeutics (PTGX),1/7/2024 10:39:43 AM
PTGX,BTIG Sticks to Their Buy Rating for Protagonist Therapeutics (PTGX),1/2/2024 2:46:02 PM
PTGX,BTIG Keeps Their Buy Rating on Protagonist Therapeutics (PTGX),12/31/2023 10:23:55 AM
PTGX,Buy Rating Affirmed for Protagonist Therapeutics Amid Positive Rusfertide Trial Updates and Promising JNJ-2113 Prospects,12/15/2023 8:00:22 AM
PTGX,Protagonist Therapeutics Earns Buy Rating on Strong Rusfertide Data and Favorable Safety Profile,12/12/2023 5:35:27 AM
PTGX,"Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), ZyVersa Therapeutics (ZVSA) and Mainz Biomed B.V. (MYNZ)",12/6/2023 11:20:40 AM
PTGX,Buy Rating for Protagonist Therapeutics: Market Dominance and Royalty Windfall from JNJ-2113’s Potential,12/5/2023 3:15:39 PM
PTGX,Protagonist Therapeutics Earns ‘Buy’ Rating on Strength of Drug Pipeline and Potential Royalties,11/15/2023 11:28:29 AM
PTGX,The Latest Analyst Ratings for Protagonist Therapeutics,11/3/2023 9:00:12 PM
PTGX,Protagonist Therapeutics’ Promising Drug JNJ-2113: A Potential Market Leader and Revenue Booster,10/10/2023 10:26:56 AM
PTGX,Promising Clinical Trials and Revenue Potential Propel Buy Rating for Protagist Therapeutics,10/9/2023 3:25:50 PM
PTGX,What 6 Analyst Ratings Have To Say About Protagonist Therapeutics,9/25/2023 6:00:19 PM
PTGX,"Analysts Are Bullish on These Healthcare Stocks: Protagonist Therapeutics (PTGX), Dynavax (DVAX)",8/4/2023 10:20:13 AM
PTGX,JMP Securities Sticks to Their Buy Rating for Protagonist Therapeutics (PTGX),8/3/2023 11:05:10 PM
PTGX,Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Quarter,7/27/2023 1:46:31 PM
PTGX,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday,7/13/2023 11:32:09 AM
PTGX,Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and KalVista Pharmaceuticals (KALV),7/10/2023 10:30:14 AM
PTGX,"Analyst Boosts Protagonist Therapeutics Price Target, Says Psoriasis Data Impressive",7/6/2023 9:48:38 PM
PTGX,JMP Securities Sticks to Their Buy Rating for Protagonist Therapeutics (PTGX),7/5/2023 8:15:05 PM
PTGX,"Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Protagonist Therapeutics (PTGX) and Arcus Biosciences (RCUS)",7/4/2023 5:21:00 AM
PTGX,Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Session,7/3/2023 7:22:26 PM
PTGX,Where Protagonist Therapeutics Stands With Analysts,6/12/2023 3:01:18 PM
PTGX,Protagonist Therapeutics (PTGX) Gets a Buy from Piper Sandler,5/19/2023 12:55:28 PM
PTGX,Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment,5/12/2023 7:14:31 PM
PTGX,Protagonist Therapeutics Announces Presentations at the 2023 Annual Congress of the European Hematology Association,5/11/2023 4:17:00 PM
PTGX,"Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Protagonist Therapeutics (PTGX) and Amneal Pharmaceuticals (AMRX)",5/8/2023 12:30:23 PM
PTGX,Protagonist GAAP EPS of -$0.67 in-line,5/5/2023 3:22:00 PM
PTGX,4 Analysts Have This to Say About Protagonist Therapeutics,4/27/2023 11:00:25 PM
PTGX,Protagonist Therapeutics (PTGX) Receives a Buy from JMP Securities,4/18/2023 6:05:28 PM
PTGX,Why Protagonist Therapeutics Shares Are Nosediving,4/5/2023 4:28:44 PM
PTGX,Protagonist falls on $100M public offering,4/4/2023 8:43:24 PM
PTGX,"3 Stocks to Buy Today, 3/16/2023, According to Top Analysts",3/16/2023 12:08:21 PM
PTGX,Protagonist GAAP EPS of -$0.69 misses by $0.10,3/15/2023 8:46:54 PM
PTGX,Top 5 Health Care Stocks That Are Ticking Portfolio Bombs,3/14/2023 1:45:47 PM
PTGX,"Sangamo, Protagonist, and Eiger among biotechs with exposure to Silicon Valley Bank",3/11/2023 2:26:19 AM
PTGX,Protagonist Therapeutics (PTGX) Gets a Buy from H.C. Wainwright,3/8/2023 1:45:09 PM
PTGX,Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,3/7/2023 7:02:26 PM
PTGX,"Analysts Offer Insights on Healthcare Companies: Cormedix (CRMD), Protagonist Therapeutics (PTGX) and Bicycle Therapeutics (BCYC)",3/1/2023 5:40:36 AM
PTGX,"GDRX, ABCL and BAND are among after hour movers",2/24/2023 10:22:34 PM
PTGX,Top 5 Health Care Stocks That May Collapse In February,2/13/2023 1:14:33 PM
PTGX,"AMRN, BHF and IMGN are among after hour movers",2/9/2023 10:59:30 PM
PTGX,JMP Securities Sticks to Its Buy Rating for Protagonist Therapeutics (PTGX),1/25/2023 3:55:59 PM
PTGX,Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Protagonist Therapeutics (PTGX),12/14/2022 5:50:09 AM
PTGX,Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Polynovo Limited (OtherCALZF),12/7/2022 10:40:41 PM
PTGX,"Analysts Are Bullish on Top Healthcare Stocks: Passage Bio (PASG), Privia Health Group (PRVA)",11/14/2022 4:10:17 AM
PTGX,JMP Securities Remains a Buy on Protagonist Therapeutics (PTGX),11/9/2022 9:15:11 PM
PTGX,Protagonist GAAP EPS of -$0.64 beats by $0.23,11/8/2022 10:44:29 PM
PTGX,"Protagonist Announces Appointment of Arturo Molina, M.D., M.S., F.A.C.P. as Chief Medical Officer",11/2/2022 9:05:00 PM
PTGX,"TTD, CRSP and MUX are among after hour movers",10/20/2022 10:01:02 PM
PTGX,"‘Stocks Are Looking Increasingly Cheap,’ Says J.P. Morgan; Here Are 2 Names to Consider",10/2/2022 11:39:07 AM
PTGX,J.P. Morgan Sticks to Its Buy Rating for Protagonist Therapeutics (PTGX),9/29/2022 1:25:10 AM
PTGX,Protagonist Therapeutics Reports Granting of Inducement Award,9/20/2022 11:53:00 PM
PTGX,Protagonist GAAP EPS of -$0.84 beats by $0.10,8/4/2022 9:34:25 PM
PTGX,"MGNI, NRIX and PTGX are among after hour and  movers",6/2/2022 8:48:06 PM
PTGX,"NRDS, PTGX and SGMO are among after hour movers",6/1/2022 9:45:17 PM
PTGX,"The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures",5/24/2022 2:24:47 PM
PTGX,"The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More",5/22/2022 9:58:01 PM
PTGX,"PTGX, MNKD and AVGO are among after hour movers",5/18/2022 9:57:52 PM
PTGX,"PTGX, FTCI and ADGI are among after hour movers",5/17/2022 8:48:34 PM
PTGX,7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years,5/11/2022 12:13:24 PM
PTGX,ACOGF: 2021 Operational & Financial Results,5/8/2022 12:11:51 PM
PTGX,Protagonist Reports First Quarter 2022 Financial Results and Provides Corporate Update,5/4/2022 10:05:00 PM
PTGX,71 Biggest Movers From Yesterday,4/27/2022 10:27:25 AM
PTGX,Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Protagonist Therapeutics Shares Plummet,4/26/2022 8:31:04 PM
PTGX,Protagonist Therapeutics Topline Data from Phase 2 IDEAL Study of PN-943 (450 mg BID) Miss Primary Endpoint,4/25/2022 11:08:33 PM
PTGX,51 Biggest Movers From Thursday,4/18/2022 11:21:57 AM
PTGX,"VSTM, ZY and SGLY among mid-day movers",4/14/2022 4:29:21 PM
PTGX,"EAR, EHTH and PTGX among after hour movers",4/13/2022 9:54:38 PM
PTGX,Asif Ali is the new finance chief at Protagonist Therapeutics,3/28/2022 11:30:15 AM
PTGX,"BiondVax, Alpha Tau top healthcare gainers; Sonendo, Creative Medical among losers",3/24/2022 2:01:47 PM
PTGX,Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech,3/16/2022 4:47:17 PM
PTGX,"CTI BioPharma, Oak Street Health top healthcare gainers; GoodRx, Semler lead losers' pack",3/1/2022 3:00:37 PM
PTGX,"Protagonist GAAP EPS of -$0.77 beats by $0.02, revenue of $8.62M beats by $4.62M",2/28/2022 10:17:07 PM
PTGX,3 Desirable Drug Stocks With Very Promising Pipelines,2/16/2022 3:39:01 PM
PTGX,"The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More",12/6/2021 12:07:24 PM
PTGX,"Protagonist To Go Ahead With Oral Peptide PN-235, Discontinues Phase 1 Candidate",12/3/2021 3:23:59 PM
PTGX,Protagonist chooses candidate to advance into phase 2 in collaboration with Janssen,12/2/2021 9:38:52 PM
PTGX,Phase 2a data supports Protagonist genetic liver disease drug rusfertide,11/15/2021 1:00:04 PM
PTGX,"The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More",11/8/2021 2:24:25 PM
PTGX,"Protagonist EPS misses by $0.02, beats on revenue",11/3/2021 9:28:47 PM
PTGX,"5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Augmented Reality Play WiMi Hologram Joins List",11/1/2021 3:00:09 PM
PTGX,"Short Squeeze Stocks: PTGX, AGC and 3 Others Experts Think Are Ready to Pop",10/25/2021 6:06:28 PM
PTGX,"The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs",10/18/2021 1:34:17 PM
PTGX,Jasper more than doubles while M&A headlines weekly healthcare performers,10/16/2021 2:04:29 AM
PTGX,10 Biggest Price Target Changes For Wednesday,10/13/2021 1:55:03 PM
PTGX,Analyst Ratings For Protagonist Therapeutics,10/12/2021 6:22:05 PM
PTGX,Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher,10/11/2021 9:17:03 PM
PTGX,Battered Protagonist Therapeutics Stock Is Primed For a Dip-Buy,10/5/2021 2:44:56 PM
PTGX,58 Biggest Movers From Yesterday,9/24/2021 11:11:19 AM
PTGX,What 6 Analyst Ratings Have To Say About Protagonist Therapeutics,9/22/2021 6:35:26 PM
PTGX,32 Stocks Moving In Tuesday's Mid-Day Session,9/21/2021 6:08:40 PM
PTGX,Mid-Afternoon Market Update: Dow Tumbles 2.5%; BeyondSpring Shares Plunge,9/20/2021 8:33:42 PM
PTGX,Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet,9/17/2021 9:10:23 PM
PTGX,"The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod",9/8/2021 1:32:08 PM
PTGX,AI-powered ETF still all-in on stocks and finding more value: Alpha Tactics,8/14/2021 7:10:49 PM
PTGX,"The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering",8/11/2021 2:14:38 PM
PTGX,Protagonist Therapeutics Announces Resolution of Contract Dispute with Zealand Pharma,8/10/2021 2:05:00 PM
PTGX,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",8/5/2021 2:07:56 PM
PTGX,Protagonist Therapeutics Reports Second Quarter 2021 Financial Results and Recent Company Progress,8/4/2021 10:05:00 PM
PTGX,"The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business",8/3/2021 1:55:12 PM
PTGX,"The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs",7/30/2021 1:53:58 PM
PTGX,Protagonist Therapeutics Announces Amendment of Agreement with Janssen Biotech for the Continued Development and Commercialization of IL-23 Antagonists,7/28/2021 10:05:00 PM
PTGX,"The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO",7/22/2021 2:18:49 PM
PTGX,"The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay",7/21/2021 1:52:07 PM
PTGX,"The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data",7/13/2021 2:05:06 PM
PTGX,"Biotech M&A may heat up with potential targets Horizon Therapeutics, Arrowhead Pharma, analyst says",7/11/2021 1:00:00 PM
PTGX,"The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures",7/2/2021 1:38:37 PM
PTGX,Protagonist Therapeutics Reports Granting of Inducement Award,6/30/2021 10:27:00 PM
PTGX,"The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout",6/29/2021 2:17:44 PM
PTGX,"The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal",6/22/2021 2:12:07 PM
PTGX,Protagonist Therapeutics closes $132M capital raise,6/18/2021 8:13:32 PM
PTGX,"The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme",6/17/2021 2:31:50 PM
PTGX,Protagonist Therapeutics Secures $115M Via Equity Raise,6/16/2021 12:53:36 PM
PTGX,"The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda",6/15/2021 2:07:38 PM
PTGX,Protagonist Therapeutics slumps 7.5% on raising $100M via public offering,6/14/2021 9:28:56 PM
PTGX,"Protagonist Stock Moves Higher As Rusfertide Shows Durability Of Effect, Symptom Improvements In Blood Cancer Trial",6/11/2021 8:09:24 PM
PTGX,"The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal",6/10/2021 2:13:41 PM
PTGX,"The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US",6/9/2021 3:14:20 PM
PTGX,"The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck",6/7/2021 2:52:10 PM
PTGX,Protagonist wins FDA Breakthrough Therapy Designation for blood cancer therapy,6/3/2021 11:27:59 AM
PTGX,"Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2021",5/24/2021 4:02:23 PM
PTGX,"The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying",5/21/2021 1:26:12 PM
PTGX,"The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics",5/19/2021 1:30:16 PM
PTGX,Protagonist gains on upcoming presentation at medical event,5/12/2021 5:18:24 PM
PTGX,"The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO",3/23/2021 1:18:20 PM
PTGX,10 Biggest Price Target Changes For Thursday,3/11/2021 2:28:41 PM
PTGX,"The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link",3/10/2021 1:25:59 PM
PTGX,The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings,3/6/2021 4:57:58 PM
PTGX,"The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal",2/17/2021 1:26:55 PM
PTGX,"Benzinga's Top Upgrades, Downgrades For January 6, 2021",1/6/2021 4:14:45 PM
PTGX,Stocks That Hit 52-Week Highs On Tuesday,12/22/2020 4:30:53 PM
PTGX,Dosing underway in Protagonist Therapeutics' early stage study with PN-235,12/16/2020 12:44:52 PM
PTGX,Protagonist Therapeutics prices $100M stock offering,12/11/2020 4:26:23 AM
PTGX,Protagonist therapeutics readies equity offering,12/10/2020 12:35:46 PM
PTGX,Protagonist Therapeutics called a ASH standout by BMO Capital,12/7/2020 4:22:44 PM
PTGX,Protagonist Therapeutics' lead program Fast Track'd for polycythemia vera,12/2/2020 12:59:00 PM
PTGX,"Protagonist Therapeutics, Janssen advance oral IL-23 receptor antagonists program",10/30/2020 10:44:17 AM
PTGX,Protagonist Therapeutics's lead asset an Orphan Drug in Europe for a type of blood cancer,10/21/2020 11:21:05 AM
PTGX,"Pre-market Movers In Healthcare Sector: CDNA, IMTX, REGN, CRSP, TLC... ",10/8/2020 12:47:23 PM
PTGX,Stock Alert: Protagonist Therapeutics Up 10%  As Hepcidin Mimetic PTG-300 Gets Orphan Drug Status ,6/18/2020 4:13:10 PM
PTGX,Protagonist Therapeutics prices upsized equity offering,5/12/2020 5:20:10 AM
PTGX,"AAOI, HEAR, RIOT and BLCM among midday movers",5/8/2020 4:44:34 PM
PTGX,What Wall Street expects from Protagonist Therapeutics's earnings,5/7/2020 3:02:03 PM
PTGX,Nomura sees 338% upside in 'overlooked' biotech,5/1/2020 9:25:44 PM
PTGX,Protagonist Therapeutics earnings: here's what Wall Street expects,3/9/2020 3:01:26 PM
PTGX,Key events next week - healthcare,2/7/2020 2:47:42 PM
PTGX,"Today's Top Gainers: PTGX Bounces Back, ALLK Abuzz, AVXL On The Move... ",12/5/2019 3:05:13 AM
PTGX,"Healthcare Stocks That Plunged To New Lows (PTGX, TRPX, MTP...) ",12/4/2019 11:09:07 AM
PTGX,"5 Top Losers In Healthcare Sector (EMMA, MBOT, XERS…) ",9/11/2019 7:40:20 AM
PTGX,Protagonist Therapeutics is about to announce its earnings — here's what to expect,3/10/2019 3:01:23 PM
PTGX,"OptiNose Dives To New Low, ReWalk Tumbles, SYN Down 60% This Month ",8/15/2018 5:03:15 AM
PTGX,"Recheck Propels PTGX, Analysts Boost Price Target On ICPT, Watch Out For AMPE ",8/7/2018 3:28:16 AM
PTGX,Protagonist Announces Phase 1 and Pre-clinical Data on Hepcidin Mimetic PTG-300 Presented at European Hematology Association Annual Meeting,6/18/2018 1:00:00 PM
PTGX,Protagonist Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference,6/6/2018 1:00:00 PM
PTGX,Protagonist Therapeutics Reports Granting of Inducement Award,6/1/2018 1:00:00 PM
PTGX,"Protagonist Therapeutics Names Samuel Saks, M.D., as Chief Development Officer",5/24/2018 10:30:00 PM
PTGX,Protagonist Therapeutics Announces Two Oral Presentations Accepted for 23rd Congress of the European Hematology Association,5/17/2018 4:14:00 PM
PTGX,Protagonist Therapeutics Appoints Bryan Giraudo to Board of Directors,5/16/2018 2:00:00 PM
PTGX,Protagonist Therapeutics Reports First Quarter 2018 Financial Results,5/9/2018 10:02:00 PM
PTGX,Sangamo Therapeutics Reports First Quarter 2018 Financial Results,5/8/2018 1:00:00 PM
PTGX,Protagonist Therapeutics Announces Oral Presentation Accepted for Digestive Diseases Week Conference,5/3/2018 2:00:00 PM
PTGX,"DXR Continues To Slide, Keep An Eye On ASNS, Data Fails To Propel PTGX ",3/27/2018 5:22:15 AM
PTGX,Protagonist Therapeutics Discontinues Phase 2b PROPEL Trial Of PTG-100 ,3/26/2018 1:48:49 PM
PTGX,An Ear To The Pharma: 11 Stocks To Watch This Week ,3/18/2018 3:36:27 AM
PTGX,Protagonist Therapeutics to Participate in the 28th Annual Oppenheimer Healthcare Conference,3/9/2018 2:00:00 PM
PTGX,FDA Grants Orphan Drug Designation for Protagonist Therapeutics' PTG-300 for the Treatment of Beta-Thalassemia,3/6/2018 10:30:00 PM
PTGX,Protagonist Therapeutics to Participate in the Barclay's Global Healthcare Conference,3/1/2018 10:00:00 PM
PTGX,"KALA Down 33% YTD, HAIR Recedes, Mark Your Calendar For Feb.23 ",2/7/2018 3:18:06 AM
PTGX,Protagonist Therapeutics to Participate in the Leerink Partners 7th Annual Global Healthcare Conference,1/31/2018 2:00:00 PM
PTGX,"AKCA ON The Move, MNLO Makes A Mark, OBSV Looks Ahead With Hope, ARGX Soars ",1/30/2018 2:19:19 AM
PTGX,Protagonist Therapeutics Granted Two New US Patents for Peptide Drug Candidates PTG-100 and PTG-300,1/4/2018 2:00:00 PM
PTGX,"Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors",12/14/2017 12:31:00 PM
PTGX,Protagonist Therapeutics to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference,12/4/2017 2:00:00 PM
PTGX,"Protagonist Therapeutics Initiates Phase 1 Trial of Oral Peptide IL-23 Receptor Antagonist, PTG-200",11/9/2017 2:00:00 PM
PTGX,"XOMA Shines, PTGX Awaits Data, SELB Implodes, No Stopping NKTR ",11/8/2017 3:07:40 AM
PTGX,Protagonist Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update,11/6/2017 10:01:00 PM
PTGX,Protagonist Therapeutics to Present at the Stifel 2017 Healthcare Conference,11/1/2017 9:17:00 PM
PTGX,"INFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints ",10/13/2017 4:06:47 AM
PTGX,"Protagonist Therapeutics Announces Preliminary Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300",9/20/2017 2:00:00 PM
PTGX,"/C O R R E C T I O N -- Protagonist Therapeutics, Inc./",9/14/2017 6:38:00 PM
PTGX,"Pacific Lifestyle Homes Builds 3,000th Home",9/12/2017 3:00:00 PM
PTGX,"ACHV Focuses On Achievement, IMGN Strikes Chord With JAZZ, FDA Snubs ACOR ",8/30/2017 5:18:07 AM
PTGX,Protagonist Therapeutics Announces Closing of Janssen License and Collaboration Agreement for PTG-200 and Receipt of $50 Million Payment,8/24/2017 10:01:00 PM
PTGX,"Gainers & Losers Of Aug.14: TTOO, TBPH, SGMO, APEN, ZYNE... ",8/15/2017 4:17:23 AM
PTGX,Protagonist Therapeutics Reports Second Quarter 2017 Financial Results and Business Highlights,8/8/2017 10:16:00 PM
PTGX,"Gainers & Losers Of July 17: ACRX, QDEL, AKCA, SGMO, SUPN... ",7/18/2017 5:40:52 AM
PTGX,"Protagonist Therapeutics Appoints Five Prime Therapeutics CEO, Lewis T. ""Rusty"" Williams, to its Board of Directors",6/8/2017 2:00:00 PM
PTGX,A small biotech wants to disrupt billion-dollar injectable drug markets with a single pill (PTGX),6/7/2017 7:12:12 PM
PTGX,"Gainers & Losers Of May 30: PTGX, ECYT, NTLA, EDIT, CNCE... ",5/31/2017 3:42:56 AM
PTGX,Protagonist Therapeutics Enters into Worldwide Agreement with Janssen to Co-Develop and Commercialize PTG-200 for Inflammatory Bowel Disease,5/30/2017 1:00:00 PM
PTGX,"Gainers & Losers Of May 24: PBYI, INO, NVCR, AKAO, NBIX... ",5/25/2017 3:53:19 AM
PTGX,"Key Patent Issues Covering Protagonist Therapeutics' Oral Peptide IL-23 Receptor Antagonists, including the Development Candidate PTG-200",5/4/2017 11:23:00 PM
PTGX,Protagonist Therapeutics Announces PTG-200 Data Accepted for Oral Presentation at Digestive Diseases Week,4/20/2017 10:21:00 PM
PTGX,Protagonist Therapeutics to Present at the Oppenheimer & Co. Healthcare Conference,3/9/2017 2:00:00 PM
PTGX,Protagonist Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results,3/7/2017 10:05:00 PM
PTGX,Protagonist Therapeutics to Present at the Barclays Global Healthcare Conference,3/2/2017 2:00:00 PM
